Breast CancerNCT07272447
Effect of Hand Message on Catheter Insertion
A study testing Hand massage in people with Breast Cancer, run by University of Yalova at 1 site in Turkey (Türkiye).
Trial summary
This is a randomized controlled study to investigate the effect of arm message on the success of peripheral intravenous catheter insertion in breast cancer patients undergoing chemotherapy. There are two groups in our study (control group=30, experimental group=30). Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Breast Cancer
- What is being tested?
- Hand massage
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Aug 2024to 1 Feb 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- diagnosed as breast cancer,
- having had the first course of chemotherapy,
- patients who has 1,2 and 3 vein degree
Who cannot join
- More than 2 unsuccessful attempts at PICK placement,
- The individual wants to leave the study
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Arm Message on the Success of Peripheral Intravenous Catheter Insertion in Breast Cancer Patients Undergoing Chemotherapy
This is a randomized controlled study to investigate the effect of arm message on the success of peripheral intravenous catheter insertion in breast cancer patients undergoing chemotherapy. There are two groups in our study (control group=30, experimental group=30). The investigator applied hand massage to patients in experimental group before peripheral intravenous catheter insertion. The investigators evaluated the succesfull peripheral catheter insertion time, anxiety level, and satisfaction level of the patients.
Read the detailed description
Introduction: Peripheral intravenous catheter (PIVK) placement becomes difficult in patients diagnosed with breast cancer who receive chemotherapy because vein visibility decreases.
Objective: The aim of this study is to determine the effect of arm massage applied to patients diagnosed with breast cancer receiving chemotherapy on the success of peripheral intravenous catheter placement.
Method: The study will conducted in a randomized controlled experimental type in an outpatient chemotherapy unit of a hospital.The sample of the study will consist of 60 patients who met the inclusion criteria (experimental group = 30, control group = 30). Patients in the experimental group will receive arm massage before peripheral intravenous catheter placement, while patients in the control group will receive no intervention. The time to successful catheter placement, patient anxiety, and satisfaction levels regarding the procedure will be recorded.
- Conditions
- Breast Cancer
- Being tested
- Hand massage
- Keywords
- vein visibility, breast cancer, peripheral catheter insertion
- Medical subject headings
- Breast Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hand massageOther
Classical hand massage that inclued effleurage, and petrisage.
| Study group | Role | What they receive |
|---|---|---|
| experimental group | Experimental | hand massage Receives: Other: Hand massage |
| control group | No intervention | no intervention has applied |
What is being measured
The primary outcome is the main question the study is designed to answer.
the success of peripheral intravenous catheter insertion
Time until successful catheter placement
Measured: assessed up to 6 months
Secondary outcomes (1)
patient satisfaction level scale
Patient satisfaction levels with peripheral intravenous catheter placement procedure
Measured: assessed up to 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Dec 2025
- Study start1 Aug 2024
- Primary completion1 Feb 2025
- Study completion1 Feb 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized controlled study
- Masking
- None (open label)
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Yalova
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Handan Eren, University of Yalova
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07272447
- Sponsor's protocol ID
- 224/187
- Status last verified
- Nov 2025
- First submitted
- 7 Jul 2025
- Last updated
- 9 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Arm Message on the Success of Peripheral Intravenous Catheter Insertion in Breast Cancer Patients Undergoing Chemotherapy
- ClinicalTrials.gov ID
- NCT07272447
- Acronym / sponsor ID
- 224/187
- Conditions
- Breast Cancer
- Keywords
- vein visibility, breast cancer, peripheral catheter insertion
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- University of YalovaUniversity, hospital or other
- Study start
- 1 Aug 2024 (actual)
- Primary completion
- 1 Feb 2025 (actual)
- Study completion
- 1 Feb 2025 (actual)
- First posted
- 9 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a randomized controlled study to investigate the effect of arm message on the success of peripheral intravenous catheter insertion in breast cancer patients undergoing chemotherapy. There are two groups in our study (control group=30, experimental group=30). The investigator applied hand massage to patients in experimental group before peripheral intravenous catheter insertion. The investigators evaluated the succesfull peripheral catheter insertion time, anxiety level, and satisfaction level of the patients.
Detailed description
Introduction: Peripheral intravenous catheter (PIVK) placement becomes difficult in patients diagnosed with breast cancer who receive chemotherapy because vein visibility decreases.
Objective: The aim of this study is to determine the effect of arm massage applied to patients diagnosed with breast cancer receiving chemotherapy on the success of peripheral intravenous catheter placement.
Method: The study will conducted in a randomized controlled experimental type in an outpatient chemotherapy unit of a hospital.The sample of the study will consist of 60 patients who met the inclusion criteria (experimental group = 30, control group = 30). Patients in the experimental group will receive arm massage before peripheral intravenous catheter placement, while patients in the control group will receive no intervention. The time to successful catheter placement, patient anxiety, and satisfaction levels regarding the procedure will be recorded.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Randomized controlled study
| Arm | Type | Receives |
|---|---|---|
| experimental group | Experimental | Other: Hand massagehand massage |
| control group | No intervention | –no intervention has applied |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (3 listed)
- diagnosed as breast cancer,
- having had the first course of chemotherapy,
- patients who has 1,2 and 3 vein degree
Key exclusion criteria (2 listed)
- More than 2 unsuccessful attempts at PICK placement,
- The individual wants to leave the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hand massageClassical hand massage that inclued effleurage, and petrisage. | Other | experimental group |
Primary outcome
the success of peripheral intravenous catheter insertion
Time frame: assessed up to 6 months
Time until successful catheter placement
1 secondary outcome
patient satisfaction level scale
Time frame: assessed up to 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Dec 2025.
- Individual participant dataSharing planned: No
Related trials for Breast Cancer
Not yet recruiting
Effect of a Health Belief Model Based Digital Nudge Intervention on Breast Cancer Screening
Breast Cancer Screening, Breast Cancer Awareness
Active, not recruitingPhase 1/2
A Beta-only IL-2 ImmunoTherapY Study
Advanced Solid Tumor, Unresectable Solid Tumor
Not yet recruitingPhase 2
Low-Dose Apatinib Plus Chemotherapy in ADC-Pretreated HER2-Positive and HER2-Low Advanced Breast Cancer
Breast Neoplasms, Advanced Breast Cancer
RecruitingPhase 3
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Breast Neoplasms
Active, not recruitingPhase 2
Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases
Breast Cancer Stage IV
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Hand massage in people with Breast Cancer, run by University of Yalova at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
the success of peripheral intravenous catheter insertion (time frame: assessed up to 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2025.